Related Experiment Video
Updated: Jul 20, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
The polycystic kidney disease-1 gene is a target for p53-mediated transcriptional repression
Diederik Van Bodegom1, Zubaida Saifudeen, Susana Dipp
1Department of Pediatrics, Section of Pediatric Nephrology, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Abstract:
This study provides evidence that the tumor suppressor protein, p53, is a transcriptional repressor of PKD1. Kidneys of p53-null mice expressed higher Pkd1 mRNA levels than wild-type littermates; gamma-irradiation suppressed PKD1 gene expression in p53+/+ but not p53-/- cells; and chromatin immunoprecipitation assays demonstrated the binding of p53 to the PKD1 promoter in vivo. In transient transfection assays, p53 repressed PKD1 promoter activity independently of endogenous p21. Deletion analysis mapped p53-mediated repression to the proximal promoter region of PKD1. Mutations of the DNA binding or C-terminal minimal repression domains of p53 abolished its ability to repress PKD1. Moreover, trichostatin A, an inhibitor of histone deacetylase activity, attenuated p53-induced repression of the PKD1 promoter. These findings, together with previous reports showing that dedifferentiated Pkd1-deficient cells express lower p53 and p21 levels, suggest a model whereby PKD1 signaling activates the p53-p21 differentiation pathway. In turn, p53 cooperates with histone deacetylases to repress PKD1 gene transcription. Loss of a p53-mediated negative feedback loop in PKD1 mutant cells may therefore contribute to deregulated PKD1 expression and cystogenesis.
Insights
The tumor suppressor protein p53 acts as a transcriptional repressor of PKD1. Loss of this p53-mediated feedback loop may drive cystogenesis in PKD1-related diseases.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Polycystic kidney disease (PKD) involves dysregulated gene expression.
- The tumor suppressor protein p53 plays a role in cell differentiation and tumor suppression.
- PKD1 is a key gene implicated in the pathogenesis of PKD.
Purpose of the Study:
- To investigate the regulatory relationship between p53 and the PKD1 gene.
- To elucidate the mechanism by which p53 influences PKD1 expression.
- To explore the potential role of this interaction in cystogenesis.
Main Methods:
- Comparison of Pkd1 mRNA levels in p53-null and wild-type mice.
- Analysis of PKD1 gene expression following gamma-irradiation in different p53 genotypes.
- Chromatin immunoprecipitation assays to detect p53 binding to the PKD1 promoter.
- Transient transfection assays with PKD1 promoter constructs.
- Site-directed mutagenesis of p53 domains.
- Treatment with trichostatin A, a histone deacetylase inhibitor.
Main Results:
- p53 directly represses PKD1 gene transcription.
- p53 binds to the proximal promoter region of PKD1.
- Repression is independent of p21 and requires functional p53 DNA binding and repression domains.
- Histone deacetylase activity is involved in p53-mediated repression of PKD1.
- PKD1 signaling appears to activate the p53-p21 pathway, forming a negative feedback loop.
Conclusions:
- p53 acts as a transcriptional repressor of PKD1, forming a negative feedback loop.
- This feedback loop involves cooperation between p53 and histone deacetylases.
- Disruption of this p53-mediated negative feedback loop in PKD1 mutant cells may contribute to aberrant PKD1 expression and cyst formation in polycystic kidney disease.
Related Concept Videos
Abnormal Proliferation
Cell Specific Gene Expression
Negative Regulator Molecules
Inhibition of Cdk Activity
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
